Transaction · 0000950170-25-007494

Elazzouzi Amy

Elazzouzi Amy, VP, reported an open-market or private sale at Aura Biosciences, Inc. involving 1001.000000 shares for an estimated $7679.17. Reported holdings after the transaction were 38442.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

Open-market sellSEC transaction code SVP
AURAAura Biosciences, Inc.
Filing timeJan 22
Trade dateJan 21, 2025
Filing · SECView on SEC
InsiderProfile

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
…
Pre-filing
…
Returns since
…

AURA price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
AURA since 2025-01-22Filed 589 days ago · 30 days of pre-filing context shaded
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
Sell
Code S
Identifier
0000950170-25-007494
Common Stock
Transaction date
Jan 21, 2025
Filed Jan 22, 2025, 02:09 AM · 1d delay
Shares
1.00k sh
$767 per share
Estimated value
-$767k
Computed from shares × price
Holdings after
38.4k sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $10.0MLarge $100M
Cluster Selling Direct Ownership
+10score
Filing-only score

+10

Compact filing score computed from stored Form 4 facts. Version v1.

Positive filing signal

This filing has a modest positive filing-only score. Treat it as a useful flag for review, not as a buy signal.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

Vice President, Finance

Officer YesDirector No10% NoOther No
Footnotes & amended
  1. F1

    The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock uni…

  2. F2

    The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.67 to $7.86, inclusive. The Reporting Person undertakes to provide…

Original filing · 0000950170-25-007494
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

AURA